MPTENs as modifiers of the PTEN/IGF pathway and methods of use

Details for Australian Patent Application No. 2004253477 (hide)

Owner Exelixis, Inc.

Inventors Mcgrath, Garth Joseph; Lickteig, Kim; Costa, Michael R.

Agent Davies Collison Cave

Pub. Number AU-A-2004253477

PCT Pub. Number WO2005/002418

Priority 60/479,768 19.06.03 US

Filing date 18 June 2004

Wipo publication date 13 January 2005

International Classifications

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/002418 Priority application(s): WO2005/002418

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004253478-Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases

2004253475-Leukocyte internalized peptide-drug conjugates